 Lauren Zell-Baran
Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Occupational Exposure | 14 | 2026 | 355 | 4.090 |
Why?
| | Coal Mining | 10 | 2024 | 23 | 2.520 |
Why?
| | Silicosis | 5 | 2026 | 30 | 2.250 |
Why?
| | Pneumoconiosis | 6 | 2024 | 20 | 1.700 |
Why?
| | Fluorocarbons | 3 | 2023 | 119 | 1.600 |
Why?
| | Lung Diseases | 5 | 2024 | 781 | 1.570 |
Why?
| | Military Personnel | 7 | 2024 | 733 | 1.560 |
Why?
| | Silicon Dioxide | 9 | 2026 | 121 | 1.500 |
Why?
| | Dust | 10 | 2026 | 101 | 1.480 |
Why?
| | Asthma | 5 | 2024 | 1774 | 1.380 |
Why?
| | Anthracosis | 7 | 2025 | 14 | 1.270 |
Why?
| | Vaccines | 2 | 2023 | 388 | 1.080 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2023 | 641 | 1.010 |
Why?
| | Spirometry | 2 | 2024 | 231 | 0.980 |
Why?
| | Mining | 1 | 2026 | 37 | 0.940 |
Why?
| | Emphysema | 2 | 2022 | 100 | 0.840 |
Why?
| | September 11 Terrorist Attacks | 2 | 2024 | 31 | 0.810 |
Why?
| | Afghan Campaign 2001- | 2 | 2024 | 193 | 0.800 |
Why?
| | Rubella | 1 | 2023 | 23 | 0.800 |
Why?
| | Mumps | 1 | 2023 | 21 | 0.800 |
Why?
| | Respiratory Function Tests | 3 | 2024 | 541 | 0.790 |
Why?
| | Measles | 1 | 2023 | 46 | 0.780 |
Why?
| | Chickenpox | 1 | 2023 | 80 | 0.770 |
Why?
| | Respiratory Tract Diseases | 1 | 2023 | 175 | 0.680 |
Why?
| | Occupational Diseases | 4 | 2025 | 165 | 0.680 |
Why?
| | Explosive Agents | 1 | 2020 | 8 | 0.660 |
Why?
| | Breath Tests | 1 | 2020 | 77 | 0.640 |
Why?
| | Inhalation Exposure | 2 | 2025 | 103 | 0.630 |
Why?
| | Pulmonary Emphysema | 1 | 2022 | 275 | 0.590 |
Why?
| | Coal | 6 | 2024 | 18 | 0.430 |
Why?
| | Lung | 12 | 2025 | 4089 | 0.420 |
Why?
| | Pulmonary Diffusing Capacity | 2 | 2024 | 78 | 0.420 |
Why?
| | Vaccination | 1 | 2022 | 1419 | 0.410 |
Why?
| | Bronchiolitis | 2 | 2025 | 87 | 0.380 |
Why?
| | Veterans | 2 | 2025 | 1614 | 0.380 |
Why?
| | Respiration Disorders | 2 | 2022 | 78 | 0.320 |
Why?
| | Humans | 30 | 2026 | 144667 | 0.300 |
Why?
| | Incidence | 2 | 2026 | 2892 | 0.270 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2024 | 200 | 0.250 |
Why?
| | Afghanistan | 3 | 2023 | 96 | 0.240 |
Why?
| | Pregnancy | 3 | 2023 | 7122 | 0.240 |
Why?
| | Forced Expiratory Volume | 2 | 2024 | 448 | 0.240 |
Why?
| | Minerals | 1 | 2026 | 48 | 0.230 |
Why?
| | Iraq War, 2003-2011 | 2 | 2024 | 171 | 0.230 |
Why?
| | Particulate Matter | 2 | 2025 | 337 | 0.230 |
Why?
| | Spectrometry, X-Ray Emission | 1 | 2024 | 6 | 0.210 |
Why?
| | Child, Preschool | 3 | 2023 | 11790 | 0.200 |
Why?
| | Sarcoidosis, Pulmonary | 1 | 2025 | 97 | 0.200 |
Why?
| | Iraq | 2 | 2022 | 66 | 0.200 |
Why?
| | Prevalence | 3 | 2026 | 2839 | 0.200 |
Why?
| | Fibrosis | 2 | 2023 | 547 | 0.200 |
Why?
| | Eye Diseases, Hereditary | 1 | 2023 | 15 | 0.190 |
Why?
| | Vital Capacity | 1 | 2024 | 290 | 0.190 |
Why?
| | Middle Aged | 11 | 2025 | 35971 | 0.190 |
Why?
| | Female | 11 | 2025 | 78304 | 0.190 |
Why?
| | Occupations | 1 | 2022 | 50 | 0.190 |
Why?
| | Pulmonary Alveolar Proteinosis | 1 | 2022 | 16 | 0.190 |
Why?
| | Linear Models | 2 | 2024 | 845 | 0.180 |
Why?
| | Retinal Detachment | 1 | 2023 | 73 | 0.180 |
Why?
| | Adult | 11 | 2025 | 40489 | 0.180 |
Why?
| | Alkanesulfonic Acids | 1 | 2022 | 34 | 0.180 |
Why?
| | Immunization Schedule | 1 | 2022 | 186 | 0.170 |
Why?
| | Male | 12 | 2025 | 72431 | 0.170 |
Why?
| | Dyspnea | 1 | 2023 | 250 | 0.160 |
Why?
| | Lung Injury | 1 | 2024 | 236 | 0.160 |
Why?
| | Immunization | 1 | 2022 | 374 | 0.160 |
Why?
| | Drinking Water | 1 | 2022 | 91 | 0.160 |
Why?
| | United States | 8 | 2025 | 16018 | 0.160 |
Why?
| | Respiratory Insufficiency | 1 | 2024 | 324 | 0.160 |
Why?
| | War Exposure | 1 | 2020 | 14 | 0.160 |
Why?
| | Manufactured Materials | 1 | 2019 | 9 | 0.150 |
Why?
| | Manufacturing Industry | 1 | 2019 | 6 | 0.150 |
Why?
| | Early Diagnosis | 1 | 2020 | 249 | 0.150 |
Why?
| | Family | 1 | 2023 | 685 | 0.140 |
Why?
| | Water Pollutants, Chemical | 1 | 2022 | 229 | 0.140 |
Why?
| | Smoking | 2 | 2025 | 1467 | 0.130 |
Why?
| | Chronic Disease | 1 | 2023 | 1810 | 0.120 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2942 | 0.120 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 919 | 0.100 |
Why?
| | Silicates | 2 | 2024 | 19 | 0.100 |
Why?
| | Child | 2 | 2023 | 22600 | 0.100 |
Why?
| | Body Mass Index | 1 | 2020 | 2419 | 0.090 |
Why?
| | Biopsy | 2 | 2025 | 1079 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2022 | 6399 | 0.080 |
Why?
| | Exercise Test | 2 | 2024 | 626 | 0.080 |
Why?
| | Prospective Studies | 1 | 2022 | 7994 | 0.080 |
Why?
| | Young Adult | 3 | 2025 | 14122 | 0.080 |
Why?
| | Infant | 1 | 2022 | 10023 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 6041 | 0.060 |
Why?
| | Risk Factors | 1 | 2020 | 10796 | 0.060 |
Why?
| | Asia, Western | 1 | 2025 | 5 | 0.060 |
Why?
| | Cross-Sectional Studies | 3 | 2022 | 5870 | 0.060 |
Why?
| | Taiwan | 1 | 2025 | 46 | 0.060 |
Why?
| | Israel | 1 | 2025 | 46 | 0.060 |
Why?
| | Smokers | 1 | 2025 | 137 | 0.050 |
Why?
| | West Virginia | 1 | 2024 | 9 | 0.050 |
Why?
| | Smoke | 1 | 2025 | 147 | 0.050 |
Why?
| | Pulmonary Gas Exchange | 1 | 2024 | 116 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2024 | 2922 | 0.050 |
Why?
| | Aged | 4 | 2025 | 25955 | 0.050 |
Why?
| | Particle Size | 1 | 2024 | 401 | 0.050 |
Why?
| | Disability Evaluation | 1 | 2024 | 310 | 0.050 |
Why?
| | Demography | 1 | 2022 | 287 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2024 | 17149 | 0.040 |
Why?
| | Exercise Tolerance | 1 | 2023 | 282 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2022 | 426 | 0.040 |
Why?
| | Oxygen Consumption | 1 | 2023 | 717 | 0.040 |
Why?
| | Washington | 1 | 2019 | 148 | 0.040 |
Why?
| | Logistic Models | 1 | 2024 | 2114 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2019 | 305 | 0.040 |
Why?
| | Texas | 1 | 2019 | 271 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2025 | 3603 | 0.030 |
Why?
| | California | 1 | 2019 | 471 | 0.030 |
Why?
| | Odds Ratio | 1 | 2020 | 1076 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2022 | 3414 | 0.030 |
Why?
| | Registries | 1 | 2022 | 2392 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2022 | 2754 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2870 | 0.020 |
Why?
| | Biomarkers | 1 | 2022 | 4261 | 0.020 |
Why?
| | Colorado | 1 | 2019 | 4558 | 0.020 |
Why?
| | Adolescent | 1 | 2025 | 22409 | 0.010 |
Why?
|
|
Zell-Baran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|